91 related articles for article (PubMed ID: 24895251)
21. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
[TBL] [Abstract][Full Text] [Related]
22. Discovery and synthesis of rocaglaol derivatives inducing apoptosis in HCT116 cells via suppression of MAPK signaling pathway.
Yang HJ; Li YN; Yan C; Yang J; Zeng YR; Yi P; Li YM; Hao XJ; Yuan CM
Fitoterapia; 2021 Jun; 151():104876. PubMed ID: 33675885
[TBL] [Abstract][Full Text] [Related]
23. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
24. [Paclitaxel induced apoptotic genes and pathways alterations: a review].
Liu D; Kang H; Sun C; Xiao Y; Zhao K
Sheng Wu Gong Cheng Xue Bao; 2013 Feb; 29(2):153-60. PubMed ID: 23697160
[TBL] [Abstract][Full Text] [Related]
25. Anti-leukemic effect of a synthetic compound, (±) trans-dihydronarciclasine (HYU-01) via cell-cycle arrest and apoptosis in acute myeloid leukemia.
Kim SJ; Park HK; Kim JY; Yoon JS; Kim ES; Cho CG; Kim BK; Park BB; Lee YY
APMIS; 2012 Oct; 120(10):836-45. PubMed ID: 22958292
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of taspine by modulating the EGFR signaling pathway of Erk1/2 and Akt in vitro and in vivo.
Zhang Y; Zheng L; Zhang J; Dai B; Wang N; Chen Y; He L
Planta Med; 2011 Nov; 77(16):1774-81. PubMed ID: 21614750
[TBL] [Abstract][Full Text] [Related]
27. Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model.
Zhuang Q; Hong F; Shen A; Zheng L; Zeng J; Lin W; Chen Y; Sferra TJ; Hong Z; Peng J
Int J Oncol; 2012 May; 40(5):1569-74. PubMed ID: 22218594
[TBL] [Abstract][Full Text] [Related]
28. Cleistanthoside A tetraacetate-induced DNA damage leading to cell cycle arrest and apoptosis with the involvement of p53 in lung cancer cells.
Wanitchakool P; Jariyawat S; Suksen K; Soorukram D; Tuchinda P; Piyachaturawat P
Eur J Pharmacol; 2012 Dec; 696(1-3):35-42. PubMed ID: 23041153
[TBL] [Abstract][Full Text] [Related]
29. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
30. Lycium barbarum polysaccharide stimulates proliferation of MCF-7 cells by the ERK pathway.
Shen L; Du G
Life Sci; 2012 Sep; 91(9-10):353-7. PubMed ID: 22921303
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways.
Li Z; Min W; Gou J
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1001-11. PubMed ID: 24036847
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex.
Sadlish H; Galicia-Vazquez G; Paris CG; Aust T; Bhullar B; Chang L; Helliwell SB; Hoepfner D; Knapp B; Riedl R; Roggo S; Schuierer S; Studer C; Porco JA; Pelletier J; Movva NR
ACS Chem Biol; 2013 Jul; 8(7):1519-27. PubMed ID: 23614532
[TBL] [Abstract][Full Text] [Related]
33. Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors.
Nilewski C; Michels TD; Xiang AX; Packard GK; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Ernst JT; Reich SH
Org Lett; 2020 Aug; 22(16):6257-6261. PubMed ID: 32806219
[TBL] [Abstract][Full Text] [Related]
34. MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents.
Peluso I; Yarla NS; Ambra R; Pastore G; Perry G
Semin Cancer Biol; 2019 Jun; 56():185-195. PubMed ID: 28912082
[TBL] [Abstract][Full Text] [Related]
35. Molecular Identification of Phytochemical for Anticancer Treatment.
Usuwanthim K; Wisitpongpun P; Luetragoon T
Anticancer Agents Med Chem; 2020; 20(6):651-666. PubMed ID: 32053086
[TBL] [Abstract][Full Text] [Related]
36. Natural flavonoids targeting deregulated cell cycle progression in cancer cells.
Singh RP; Agarwal R
Curr Drug Targets; 2006 Mar; 7(3):345-54. PubMed ID: 16515531
[TBL] [Abstract][Full Text] [Related]
37. Investigating into anti-cancer potential of lycopene: Molecular targets.
Qi WJ; Sheng WS; Peng C; Xiaodong M; Yao TZ
Biomed Pharmacother; 2021 Jun; 138():111546. PubMed ID: 34311540
[TBL] [Abstract][Full Text] [Related]
38. Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae).
Ebada SS; Lajkiewicz N; Porco JA; Li-Weber M; Proksch P
Prog Chem Org Nat Prod; 2011; 94():1-58. PubMed ID: 21833837
[No Abstract] [Full Text] [Related]
39. In Search of Panacea-Review of Recent Studies Concerning Nature-Derived Anticancer Agents.
Przystupski D; Niemczura MJ; Górska A; Supplitt S; Kotowski K; Wawryka P; Rozborska P; Woźniak K; Michel O; Kiełbik A; Bartosik W; Saczko J; Kulbacka J
Nutrients; 2019 Jun; 11(6):. PubMed ID: 31242602
[TBL] [Abstract][Full Text] [Related]
40. Toward the mechanism of eIF4F-mediated ribosomal attachment to mammalian capped mRNAs.
Kumar P; Hellen CU; Pestova TV
Genes Dev; 2016 Jul; 30(13):1573-88. PubMed ID: 27401559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
